BIOCRYST PHARMACEUTICA

NetDania - New 12 months High: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK

07 أغسطس 2024 08:45:08 بحسب NetDania Notify

BioCryst Reports Second Quarter 2024 Financial Results and Provides Business Update

05 أغسطس 2024 06:00:24 بحسب Nasdaq GlobeNewswire

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 أغسطس 2024 06:00:47 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK

29 يوليو 2024 08:56:40 بحسب NetDania Notify

BioCryst to Report Second Quarter 2024 Financial Results on August 5

22 يوليو 2024 06:00:09 بحسب Nasdaq GlobeNewswire

ORLADEYO® (berotralstat) Approved in Peru

09 يوليو 2024 06:00:00 بحسب Nasdaq GlobeNewswire

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 يوليو 2024 06:00:06 بحسب Nasdaq GlobeNewswire

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 يونيو 2024 06:00:59 بحسب Nasdaq GlobeNewswire

BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO® (berotralstat) Treatment

02 يونيو 2024 03:00:13 بحسب Nasdaq GlobeNewswire

BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology

14 مايو 2024 06:00:53 بحسب Nasdaq GlobeNewswire

ORLADEYO® (berotralstat) Approved in Mexico

13 مايو 2024 06:00:00 بحسب Nasdaq GlobeNewswire

BioCryst Presents New Real-world Evidence Showing Significant Reductions in Healthcare Resource Utilization Among Patients with HAE Following Initiation of ORLADEYO® (berotralstat)

09 مايو 2024 06:00:00 بحسب Nasdaq GlobeNewswire

BioCryst to Present at Upcoming Investor Conferences

07 مايو 2024 06:00:22 بحسب Nasdaq GlobeNewswire

BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update

06 مايو 2024 06:00:00 بحسب Nasdaq GlobeNewswire

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 مايو 2024 06:00:07 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK

25 أبريل 2024 08:45:08 بحسب NetDania Notify

NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK

24 أبريل 2024 08:54:30 بحسب NetDania Notify

BioCryst to Report First Quarter 2024 Financial Results on May 6

22 أبريل 2024 06:00:50 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK

19 أبريل 2024 10:04:56 بحسب NetDania Notify

BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory Agency

17 أبريل 2024 03:30:39 بحسب Nasdaq GlobeNewswire